Personalized peptide vaccines: a new therapeutic modality for cancer. - Wikidata - awgldk - TriplyDB

Personalized peptide vaccines: a new therapeutic modality for cancer.

Personalized peptide vaccines: a new therapeutic modality for cancer.

http://www.wikidata.org/entity/Q36597682

about

Immunotherapeutic approaches in biliary tract carcinoma: Current status and emerging strategies Peptide-Based Treatment: A Promising Cancer Therapy Personalized peptide vaccination for cervical cancer patients who have received prior platinum-based chemotherapy.Personalized peptide vaccination for advanced biliary tract cancer: IL-6, nutritional status and pre-existing antigen-specific immunity as possible biomarkers for patient prognosis Phase I clinical study of a personalized peptide vaccination available for six different human leukocyte antigen (HLA-A2, -A3, -A11, -A24, -A31 and -A33)-positive patients with advanced cancer.Personalized peptide vaccination: a novel immunotherapeutic approach for advanced cancer Medical treatment of pancreatic cancer.Peptide-based immunotherapeutic approaches to glioma: a review.Randomized Phase II Study of Docetaxel plus Personalized Peptide Vaccination versus Docetaxel plus Placebo for Patients with Previously Treated Advanced Wild Type EGFR Non-Small-Cell Lung Cancer Juzentaihoto Failed to Augment Antigen-Specific Immunity but Prevented Deterioration of Patients' Conditions in Advanced Pancreatic Cancer under Personalized Peptide Vaccine.Application of pharmacogenomics to vaccines.Current status of immunotherapy for the treatment of biliary tract cancer.Cellular Immune Responses for Squamous Cell Carcinoma Antigen Recognized by T Cells 3 in Patients with Hepatocellular Carcinoma.Immunological therapy in urological malignancy: novel combination strategies.Ultrasound-based combination therapy: potential in urologic cancer.Variation of tumor-infiltrating lymphocytes in human cancers: controversy on clinical significance.Next-generation peptide vaccines for advanced cancer.Immunotherapy of biliary tract cancer.Immunotherapeutic Approaches to Biliary Cancer.Prospect and progress of personalized peptide vaccinations for advanced cancers.Combinational delivery of lipid-enveloped polymeric nanoparticles carrying different peptides for anti-tumor immunotherapy.Regulation of HLA-DR peptide occupancy by histone deacetylase inhibitors.Identification of Lck-derived peptides applicable to anti-cancer vaccine for patients with human leukocyte antigen-A3 supertype alleles.Evaluation of prognostic significance of granulocyte-related factors in cancer patients undergoing personalized peptide vaccination.Phase II study of personalized peptide vaccination for castration-resistant prostate cancer patients who failed in docetaxel-based chemotherapy.Comparative analysis of various tumor-associated antigen-specific t-cell responses in patients with hepatocellular carcinoma.Tools for Vaccine Design: Prediction and Validation of Highly Immunogenic and Conserved Class II Epitopes and Development of Epitope-Driven Vaccines

P2860

Q26776184-C441D70A-C270-4A70-96B8-82EDBCC6E4AA Q26777032-5AECD709-6AE2-4283-B5DC-962B7F8FB02C Q36092845-18F0C100-4E69-401F-9983-ABCB30DC2B9A Q36224475-0EAE9391-3738-4022-A5C7-338243A0ED95 Q36230559-476250D5-1BD4-4B91-AA0F-75BF588D7045 Q36631314-C8E54B34-3788-4196-98C8-6477AE730249 Q36788494-ECCD2E64-D866-4F12-94BA-2C7ED1541BBB Q36810278-8E102B1F-CFAD-4A13-9CBE-909241FFE9FA Q36909904-6C24E579-191B-4E50-9093-E278936EC841 Q36953449-29C35CF6-566A-46D2-B089-6111BEB39366 Q37293663-61195C77-C90B-4A67-B2A3-F52F0A982E5D Q37505379-B0BD11E4-C691-49CF-81E7-314DA0CD1ADB Q37600523-9B2B0EBD-E002-4A3E-BFE4-7805D1697300 Q37809109-9EB0129A-78DC-4B11-9B78-B95A700648D2 Q37821902-FE017274-96DC-44B0-8FA2-3A6796FB046A Q37945304-5AD534EF-C840-44A6-B4AF-C480849B31D9 Q38056246-1D4ABB5B-4DF1-4AA0-B1FD-2B4B68C62F87 Q38686339-A2E8A81F-B7D5-46DB-9BA6-FA38A1F59868 Q38703148-D162BA3D-60B6-4F72-A0D6-3E10B9AE6778 Q38758988-9B9E9D36-E946-4BBA-9BB5-002F1CE0E589 Q39117175-886D6BB5-EDA4-430A-931D-0FC332C32477 Q39208861-370AC850-6577-46DC-98E1-A55AF7B76245 Q40043739-2F6A248C-B3DB-4D6B-9A7B-EFF0A3683812 Q41364250-35D0E78D-2ECA-4322-ABF3-A7BABCD0A7E6 Q44424699-06A19F0A-4A7A-4CBB-BC34-9B6BCF8FE9A8 Q51013344-14129970-9DB7-4FD3-8DD5-7944900587E8 Q57537566-8C09177E-2FA8-48E2-BB46-F1D015B89462

P2860

Personalized peptide vaccines: a new therapeutic modality for cancer.

http://www.wikidata.org/entity/Q36597682

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Personalized peptide vaccines: a new therapeutic modality for cancer.

@ast

Personalized peptide vaccines: a new therapeutic modality for cancer.

@en

type

label

Personalized peptide vaccines: a new therapeutic modality for cancer.

@ast

Personalized peptide vaccines: a new therapeutic modality for cancer.

@en

prefLabel

Personalized peptide vaccines: a new therapeutic modality for cancer.

@ast

Personalized peptide vaccines: a new therapeutic modality for cancer.

@en

P1433

Q36597682-4650031E-665B-416C-B795-88565D7E4A0F

P1476

Q36597682-3E8C3A52-6153-4613-AB4D-861D15FE8743

P2093

Q36597682-0B950A84-E8DB-47FB-9556-6E543CB2526A

Q36597682-53AF4A47-34C5-478C-99E9-65125726F5CB

P2860

Q36597682-098995A1-B24C-4B43-A8FC-5E86C618BAEA

Q36597682-234028F4-751E-4510-B227-23FF7308CB85

Q36597682-49C28985-699A-4C01-8CD5-5DBE4D5888C5

Q36597682-528ED4B3-9E04-4B20-98A7-04E1B78690FC

Q36597682-792589A2-3D49-448A-AE58-C5FBEB03A6D7

Q36597682-825298EB-03C1-460F-ACC4-8E9084757A2B

Q36597682-8449D27C-E1A1-47DE-A480-0BBCCDF3EA85

Q36597682-963ECDD2-AAA1-46D1-BD0E-E8CEC3046A44

Q36597682-AE29A371-6039-4144-AEFE-A50654D9AC8F

Q36597682-C9767D2E-D398-4928-B6F2-7AF0DC20DA64

P304

Q36597682-DA4DADAB-B014-4697-BF7B-D1EBB2A9AFDE

P31

Q36597682-FE3E854F-29B5-4D6F-B69D-9471AD272DA5

P356

Q36597682-F13E98D8-F387-4896-8D3B-5CA7E78F253D

P433

Q36597682-E8DB4C01-15D2-4276-885E-F427D986FF2F

P478

Q36597682-93532937-A404-4829-846F-138FB6C6C132

P577

Q36597682-0DB9B87D-85EB-41FB-AFDA-96ADF80458A6

P5875

Q36597682-6BC6E7C3-A75F-4A3E-8BCF-F41F7EAE584B

P698

Q36597682-8C38E4B6-95FA-43E7-B6E5-E788D02F77AB

P356

J.1349-7006.2006.00272.X

P1433

P1476

Personalized peptide vaccines: a new therapeutic modality for cancer.

@en

P2093

Akira Yamada

http://www.w3.org/2001/XMLSchema#string

Kyogo Itoh

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer immunotherapy: moving beyond current vaccines

A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening

Biography of Constance L Cepko.

Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine

Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor.

A phase I trial of cytotoxic T-lymphocyte precursor-oriented peptide vaccines for colorectal carcinoma patients

Immunological evaluation of peptide vaccination for patients with gastric cancer based on pre-existing cellular response to peptide.

Peptide vaccination for patients with melanoma and other types of cancer based on pre-existing peptide-specific ctotoxic T-lymphocyte precursors in the periphery.

Induction of cellular and humoral immune responses to tumor cells and peptides in HLA-A24 positive hormone-refractory prostate cancer patients by peptide vaccination.

Immunological monitoring during combination of patient-oriented peptide vaccination and estramustine phosphate in patients with metastatic hormone refractory prostate cancer.

P304

970-976

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1349-7006.2006.00272.X

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

97

http://www.w3.org/2001/XMLSchema#string

P577

2006-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6810746

http://www.w3.org/2001/XMLSchema#string

P698

16984371

http://www.w3.org/2001/XMLSchema#string